Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

<ul>
<li>VATAI, a cross-border e-commerce compliance service platform, has filed its prospectus with the HKEX. CICC and Shenwan Hongyuan are the joint sponsors.</li>
<li>We look at the company's core segments: environmental compliance and corporate and tax compliance.</li>
<li>We then look at the company's financial profile, net margin dilution, pre-IPO valuation and investor backing.</li>
</ul>


VATAI, a cross-border e-commerce compliance service platform, has filed its prospectus with the HKEX. CICC and Shenwan Hongyuan are the joint sponsors.
We look at the company's core segments: environmental compliance and corporate and tax compliance.
We then look at the company's financial profile, net margin dilution, pre-IPO valuation and investor backing.


Hong Kong

Vatai Holdings Limited is an AI-empowered global platform providing cross-border e-commerce compliance services. According to CIC, the company was the largest cross-border e-commerce compliance service provider globally and in China in 2025 by sales value, and is seeking a primary listing on HKEX.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Vatai Holdings (VATAI HK)

VATAI (欧税通) Pre-IPO: Tearsheet

VATAI has filed its prospectus with the HKEX. In this tearsheet, we look at the company's business and operating profile, its industry backdrop,...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)